![](/img/cover-not-exists.png)
Patient reported outcomes in anti-PD-1/PD-L1 inhibitor immunotherapy registration trials: FDA analysis of data submitted and future directions
King-Kallimanis, Bellinda L, Howie, Lynn J, Roydhouse, Jessica K, Singh, Harpreet, Theoret, Marc R, Blumenthal, Gideon M, Kluetz, Paul GLanguage:
english
Journal:
Clinical Trials
DOI:
10.1177/1740774519836991
Date:
March, 2019
File:
PDF, 147 KB
english, 2019